Perrigo Company (PRGO) Securities Fraud Investigation

Shamis & Gentile, P.A. is investigating claims on behalf of investors of Perrigo Company plc ("Perrigo" or the "Company") (PRGO). Impacted investors are advised to contact the firm now.

What the Investigation Is About

The law firm is investigating whether Perrigo and certain of its officers or directors made false or misleading statements or failed to disclose material information regarding the Company’s infant formula business, including its operational performance, safety practices, and regulatory compliance between November 2022 and November 2025.

During this period, Perrigo announced a $170 million acquisition of Nestlé’s Gateway plant and the Good Start brand, describing the transaction as a long-term investment to strengthen U.S. manufacturing and improve supply reliability. Less than a year later, on August 30, 2023, the U.S. Food and Drug Administration issued a warning letter to the Wisconsin facility acquired in that deal, citing compliance deficiencies later detailed in the Company’s filings. In August 2024, Perrigo filed an 8-K reporting a voluntary recall of roughly 16,500 cans of infant formula, which may have signaled continuing operational or regulatory challenges.

On November 5, 2025, Perrigo announced a strategic review of its infant formula business and a reassessment of a $240 million investment. The Company also reduced its full-year 2025 earnings guidance from $2.90–$3.10 per share to $2.70–$2.80 per share.

Market Reaction

Following the disclosure, Perrigo’s stock fell approximately 25%, dropping from $20.19 at close on November 4 to $15.10 on November 5, 2025, resulting in significant investor losses.

What Investors Can Do

If you purchased or otherwise acquired Perrigo (PRGO) securities between November 2022 and November 2025, you may be eligible to seek compensation for your losses. Contact Shamis & Gentile, P.A. today to discuss your options.

Shamis & Gentile, P.A. stands out as an advocate for investors who are victims of securities fraud. The firm is committed to securing recoveries for investors who have incurred damages due to false and misleading statements or other corporate misconduct by public companies. Shamis & Gentile has recovered over $1 billion for consumers nationwide. Its extensive experience, expertise and resources enable the firm to resolve disputes in a wide range of matters, including class actions, mass torts and mass arbitrations.

Attorney advertising. Prior results do not guarantee similar outcomes.